Diseases of the brain are devastating and growing at a fast rate
Neurology • Psychiatry • Sensory disorders
1st direct and indirect healthcare cost in the world
850 B€of yearly annual cost in Europe
1st cause of healthy life year loss in the world
1st cause of invalidity in the world
60%of yearly annual cost in Europe
1st perceived threat to individual dignity in the population
60% more medication for mental health in the past 10 years
Context
Mental health needs are on the rise
Context
With recent methodological breakthroughs in research a new industry ecosystem is growing and investments are on the rise
Braintech VC funding (USA)
Braintech VC funding (EU)
Founders & Partners
Major research Institutes in Paris region such as Paris Brain Institute, FondaMental foundation, Vision Institute have initiated a translational research engine supporting innovation and industry growth
Major Hospitals and clinical networks
+100,000 individual patients/year
Experienced clinical Research Centers
+20 National Rare Disease Reference Centers
+ 100,000 new patients/year
Multimodal biomarkers
Technology acceleration units
+80 start-ups | +300 industry partners
Homelab
Hospital living lab
Fast prototyping
4 dedicated bioincubators within 500m radius
Translational research Institutes
+1,000 research personnels
Developmental Biology
Genetics/Genomics
Physiology/Restoration ; Robotics, Maths
Photonics
Pathophysiology/Therapeutics
Founders & Partners
Objectives
To transform the Neuroscience ecosystem, Brain&Mind will invest in three major areas
The early derisking of neuroscience technologies (biotech, medtech, prevention)
VC-coached data-package building
Entrepreneurial launchpad
Scientific evidence reinforcemen
Successful clinical development of innovative products
Scale-up of multimodal biomarkers
New clinical methododologies and RWE
Cooperative research infrastructure
Training of the next generation of engineers, entrepreneurs, caregivers